GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carilex Medical Inc (ROCO:7726) » Definitions » 3-Year EBITDA Growth Rate

Carilex Medical (ROCO:7726) 3-Year EBITDA Growth Rate : -20.80% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Carilex Medical 3-Year EBITDA Growth Rate?

Carilex Medical's EBITDA per Share for the six months ended in Dec. 2024 was NT$0.74.

During the past 12 months, Carilex Medical's average EBITDA Per Share Growth Rate was -51.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Carilex Medical was -11.10% per year. The lowest was -20.80% per year. And the median was -15.95% per year.


Competitive Comparison of Carilex Medical's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Carilex Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carilex Medical's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carilex Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Carilex Medical's 3-Year EBITDA Growth Rate falls into.


;
;

Carilex Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Carilex Medical  (ROCO:7726) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Carilex Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Carilex Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Carilex Medical Business Description

Traded in Other Exchanges
N/A
Address
No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.

Carilex Medical Headlines

No Headlines